Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adalimumab induced exacerbation of psoriasis in patients with combined pemphigus: A case report. | Medicine (Baltimore) | 2024 | 38277534 | PubTator, text mining | PubMed |
| Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study. | Acta Derm Venereol | 2024 | 38270257 | PubTator, text mining | PubMed |
| Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial. | JAMA Dermatol | 2024 | 38265821 | PubTator, text mining | PubMed |
| Gingival Manifestations in Oral Chronic Autoimmune Bullous Diseases: A Retrospective Study. | Medicina (Kaunas) | 2024 | 38256427 | PubTator, text mining | PubMed |
| Gastrointestinal Comorbidities Associated with Atopic Dermatitis-A Narrative Review. | Int J Mol Sci | 2024 | 38256267 | PubTator, text mining | PubMed |
| Fibrous Remodeling in Eosinophilic Esophagitis: Clinical Facts and Pathophysiological Uncertainties. | Int J Mol Sci | 2024 | 38256003 | PubTator, text mining | PubMed |
| Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris? | Antibodies (Basel) | 2024 | 38247568 | PubTator, text mining | PubMed |
| Unravelling the mystery: severe dermatitis, multiple allergies and metabolic wasting (SAM) syndrome with a novel homozygous mutation in DSG1. | Clin Exp Dermatol | 2024 | 38240109 | PubTator, text mining | PubMed |
| JNK inhibition enhances cell-cell adhesion impaired by desmoglein 3 gene disruption in keratinocytes. | Histochem Cell Biol | 2024 | 38227055 | PubTator, text mining | PubMed |
| A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration. | J Dermatol | 2024 | 38214494 | PubTator, text mining | PubMed |
| Cleavage of cell junction proteins as a host invasion strategy in leptospirosis. | Appl Microbiol Biotechnol | 2024 | 38204132 | PubTator, text mining | PubMed |
| The LINC01176-miR-218-5p-IL-36G Network is Responsible for the Pathogenesis of Psoriasis by Promoting Inflammation. | Clin Cosmet Investig Dermatol | 2024 | 38193028 | PubTator, text mining | PubMed |
| A fluorescence imaging technique suggests that sweat leakage in the epidermis contributes to the pathomechanism of palmoplantar pustulosis. | Sci Rep | 2024 | 38172327 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa. | J Clin Invest | 2024 | 38051587 | PubTator, text mining | PubMed |
| Role and function of plakophilin 3 in cancer progression and skin disease. | Cancer Sci | 2024 | 38048779 | PubTator, text mining | PubMed |
| Treatment with a red-laser-based wound therapy device exerts positive effects in models of delayed keratinocyte and fibroblast wound healing. | Photodermatol Photoimmunol Photomed | 2024 | 37957888 | PubTator, text mining | PubMed |
| Integrative single-cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus. | J Autoimmun | 2024 | 37939532 | PubTator, text mining | PubMed |
| Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris. | J Invest Dermatol | 2024 | 37717934 | PubTator, text mining | PubMed |
| Identification of potential hub genes associated with atopic dermatitis-like recombinant human epidermal model using integrated transcriptomic and proteomic analysis. | Biomol Biomed | 2024 | 37540585 | PubTator, text mining | PubMed |
| Association of Human Endogenous Retrovirus-W (HERV-W) Copies with Pemphigus Vulgaris. | Curr Mol Med | 2024 | 37078354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=11